Julia A. Haller | |
---|---|
Born | |
Education |
|
Medical career | |
Profession | Ophthalmologist |
Institutions | Wills Eye Hospital Sidney Kimmel Medical College at Thomas Jefferson University |
Sub-specialties | Retina |
Research |
|
Website | www |
Julia A. Haller is an American ophthalmologist who is a Professor and Chair of the Department of Ophthalmology at Sidney Kimmel Medical College at Thomas Jefferson University. [1] She also holds the William Tasman, M.D. Endowed Chair at Wills Eye Hospital in Philadelphia, where she is Ophthalmologist-in-Chief. [2]
Haller attended the Bryn Mawr School. [2] She received her A.B. from Princeton University, [3] magna cum laude. She received her medical training at Harvard Medical School, followed by an internship at Johns Hopkins and a fellowship in ocular pathology at Manhattan Eye, Ear and Throat Hospital. Her residency was at the Wilmer Eye Institute at Johns Hopkins Hospital, followed by a retina fellowship at Hopkins. She was appointed the first female Chief Resident at Wilmer in 1986.
Haller became the inaugural Katharine Graham Professor of Ophthalmology at Wilmer Eye Institute in 2002. [4] She also became the first holder of the Robert Bond Welch, M.D. Professorship of Ophthalmology there in 2006. [5] : 9–11 At Wilmer, she directed the Retina Fellowship Training Program from 2001 to 2007.
In 2007, she became the Ophthalmologist-in-Chief of Wills Eye Hospital and co-director of the Wills Vision Research Center at Jefferson. She also is an attending surgeon at Children's Hospital of Philadelphia in the Division of Ophthalmology.[ citation needed ]
Haller is a member of the National Academy of Medicine, numerous international scientific advisory boards, and sits on the Board of Trustees of the Association of University Professors of Ophthalmology (AUPO), the College of Physicians of Philadelphia, and the Society of Heed Fellows. [6] She is former president of the Women in Medicine Legacy Foundation. Haller joined the Board of Directors of Celgene [7] In 2015 and Outlook Therapeutics in 2022.
She serves on the Board of the Johns Hopkins Medical and Surgical Association, and the Philadelphia Orchestra, and is a past member of the Board of Trustees of Princeton University.[ citation needed ]
Her honors [8] include:
Haller has published over 400 scientific articles and book chapters. [14]
Ophthalmology is a surgical subspecialty within medicine that deals with the diagnosis and treatment of eye disorders. A former term is oculism.
Marshall Miller Parks was an American ophthalmologist known to many as "the father of pediatric ophthalmology".
Wills Eye Hospital is a non-profit eye clinic and hospital in Philadelphia, Pennsylvania. It was established in 1832 and is the oldest continually operating eye-care facility in the United States. It is the ophthalmology residency program for Thomas Jefferson University.
Fight for Sight is a nonprofit organization in the United States which funds medical research in vision and ophthalmology. It was formed in 1946 as the National Council to Combat Blindness (NCCB), the first non-profit organization in the United States to fund vision research; 2011 marked its 65th anniversary.
David Paton is a retired ophthalmologist best known as founder in 1970 of Project Orbis and thereafter as its first Medical Director helping to develop (1970–1982) and then deploy its teaching aircraft for ophthalmologists worldwide, especially in the developing nations. Paton resigned from Orbis in 1987 and focused on other aspects of academic ophthalmology, but in 2011 he returned in a voluntary capacity to assist in fund raising for a new annual appointment, the David Paton Orbis Fellowship in Global Ophthalmology.
Joel S. Schuman, MD, FACS is Professor of Ophthalmology, the Kenneth L. Roper Endowed Chair, Vice Chair for Research Innovation and co-director of the Glaucoma Service at Wills Eye Hospital. Prior to this he was the Elaine Langone Professor and Vice Chair for Research in the Department of Ophthalmology at NYU Langone Medical Center, NYU Grossman School of Medicine; Professor of Biomedical Engineering and Electrical & Computer Engineering at NYU Tandon School of Engineering and Professor of Neural Science in the Center for Neural Science at NYU College of Arts and Sciences. He chaired the ophthalmology department at NYU Langone Health, NYU Grossman School of Medicine 2016–2020, and was Vice Chair for Ophthalmology Research in the department 2020–2022. Prior to arriving at NYU in 2016, he was Distinguished Professor and Chairman of Ophthalmology, Eye and Ear Foundation Endowed Chair in Ophthalmology, Director of UPMC Eye Center (2003-2016) and before that was at Tufts University 1991–2003, where he was Residency Director (1991-1999) and Glaucoma and Cataract Service Chief (1991-2003). In 1998 he became Professor of Ophthalmology, and Vice Chair in 2001.
Reza Dana is the Claes H. Dohlman Professor of Ophthalmology, senior scientist and W. Clement Stone Clinical Research Scholar at Massachusetts Eye and Ear, Harvard Medical School, and director of the Harvard-Vision Clinical Scientist Development Program.
Joan Whitten Miller is a Canadian-American ophthalmologist and scientist who has made notable contributions to the treatment and understanding of eye disorders. She is credited for developing photodynamic therapy (PDT) with verteporfin (Visudyne), the first pharmacologic therapy for retinal disease. She also co-discovered the role of vascular endothelial growth factor (VEGF) in eye disease and demonstrated the therapeutic potential of VEGF inhibitors, forming the scientific basis of anti-VEGF therapy for age-related macular degeneration (AMD), diabetic retinopathy, and related conditions.
Mark S. Humayun is a Pakistani-American ophthalmologist, engineer, scientist, inventor and academic – the only ophthalmologist elected a member of both U.S. National Academies of Medicine and Engineering. He is a university professor with joint appointments at the Keck School of Medicine of USC and the USC Viterbi School of Engineering.
Emily Ying Chew is an American ophthalmologist and an expert on the human retina with a strong clinical and research interest in diabetic eye disease and age-related eye diseases. She currently works for the National Eye Institute (NEI) at the National Institutes of Health (NIH) in Bethesda, Maryland, where she serves as deputy director of the Division of Epidemiology and Clinical Applications (DECA) and the Institute's deputy clinical director. She designs and implements Phase 1, 2 and 3 clinical trials at the NIH Clinical Center. Chew is board certified in ophthalmology.
John Donald MacIntyre Gass was a Canadian-American ophthalmologist, one of the world's leading specialists on diseases of the retina. He was the first to describe many macular diseases.
Frank Burton Walsh was a Canadian-American ophthalmologist known for his work in neuro-ophthalmology. For most of his career, Walsh worked as a neuro-ophthalmologist at the Wilmer Eye Institute of Johns Hopkins Hospital. Walsh is best known for his textbook Clinical Neuro-Ophthalmology, which contains a compilation of Walsh's case reports and the conclusions he drew from them. Originally published in 1947, the textbook has many updated versions and is still a premier text in the field of neuro-ophthalmology. Walsh is considered by many to be the father of neuro-ophthalmology due to his contributions to the field.
Vadrevu K. (VK) Raju is a board-certified ophthalmologist.
Dr. William Tasman (1929–2017) an American ophthalmologist, was the ophthalmologist-in-chief at Wills Eye Hospital His work had a profound impact on the treatment of retinopathy of prematurity (ROP). He served as the president of the American Academy of Ophthalmology, the president of the American Ophthalmological Society, the president of the Retina Society, the editor for Duane's Clinical Ophthalmology, and the editor for Survey of Ophthalmology,
Dimitri Azar is an American ophthalmologist, professor, and businessman who leads Twenty Twenty Therapeutics, a joint venture established by Santen and Verily. Azar has held roles at Novartis and Verily, Alphabet's Life sciences research organization. He served as dean of the College of Medicine at the University of Illinois at Chicago (UIC) from 2011 to 2018.
Steven J. Fliesler is an American biochemist and cell biologist, whose research has focused on how lipid metabolism supports the normal structure and function of the vertebrate retina. He currently is the Meyer H. Riwchun Endowed Chair Professor of Ophthalmology and vice-chair and director of research in the department of ophthalmology, Jacobs School of Medicine and Biomedical Sciences, at the University at Buffalo, The State University of New York. In 2014, he became a UB Distinguished Professor, and in 2018 was promoted to the rank of SUNY Distinguished Professor. He is the author or coauthor of more than 150 publications, including peer-reviewed scientific/biomedical journal articles, books and book chapters.
Alfredo Arrigo Sadun is an American ophthalmologist, academic, author and researcher. He holds the Flora L. Thornton Endowed Chair at Doheny Eye Centers-UCLA and is Vice-Chair of Ophthalmology at UCLA.
Neil M. Bressler is an American ophthalmologist. He is the James P. Gills Professor of Ophthalmology and chief of the Retina Division at the Wilmer Eye Institute at Johns Hopkins School of Medicine and editor-in-chief of JAMA Ophthalmology.
Adrienne Williams Scott is an American ophthalmologist specialized in diabetic retinopathy, epiretinal membranes, and macular degeneration. She is chief of the Wilmer Eye Institute in Bel Air, Harford County, Maryland. She is an associate professor of ophthalmology at Johns Hopkins School of Medicine.
Sheila Kay West is an American ophthalmologist who is the El-Maghraby Professor of Preventive Ophthalmology at the Wilmer Eye Institute. She is also the vice-chair for Research.